Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: Biological implications
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (N01-CO-12400, HHSN261200800001E)
This publication has 78 references indexed in Scilit:
- The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturationVirology, 2010
- Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domainProceedings of the National Academy of Sciences, 2010
- C-terminal Domain Modulates the Nucleic Acid Chaperone Activity of Human T-cell Leukemia Virus Type 1 Nucleocapsid Protein via an Electrostatic MechanismJournal of Biological Chemistry, 2010
- Peeling back the mystery of DNA overstretchingProceedings of the National Academy of Sciences, 2009
- HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 InfectivityJournal of Biological Chemistry, 2009
- Nucleocapsid protein function in early infection processesVirus Research, 2008
- Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3GNucleic Acids Research, 2007
- Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid proteinNucleic Acids Research, 2007
- Interactions between HIV-1 Gag Molecules in Solution: An Inositol Phosphate-mediated SwitchJournal of Molecular Biology, 2007
- Conformation of the HIV-1 Gag Protein in SolutionJournal of Molecular Biology, 2006